ID

26084

Beschrijving

A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer Whose Disease Has Progressed on or After Trastuzumab; ODM derived from: https://clinicaltrials.gov/show/NCT00567879

Link

https://clinicaltrials.gov/show/NCT00567879

Trefwoorden

Versies (1)
  1. 09-10-17 09-10-17 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

9 oktober 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT00567879

Engels

Eligibility Breast Cancer NCT00567879

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
age > 18 year old
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
confirmed her2+ ve metastatic breast cancer
Beschrijving

Secondary malignant neoplasm of female breast HER2/Neu Positive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0346993
UMLS CUI [1,2]
C2348909
prior treatment and progression on trastuzumab
Beschrijving

Trastuzumab | Disease Progression

Datatype

boolean

Alias
UMLS CUI [1]
C0728747
UMLS CUI [2]
C0242656
patients must have adequate laboratory values
Beschrijving

Normal Laboratory Test Result

Datatype

boolean

Alias
UMLS CUI [1]
C0438214
eastern cooperative oncology group (ecog) performance status of <2
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with active central nervous system (cns) disease or brain metastases except those who have been previously treated and have been stable for at least 3 months.
Beschrijving

CNS disorder | Metastatic malignant neoplasm to brain | Exception Prior Therapy | Exception Stable status

Datatype

boolean

Alias
UMLS CUI [1]
C0007682
UMLS CUI [2]
C0220650
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1514463
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0205360
impaired heart function or clinically significant heart disease
Beschrijving

Cardiac function Impaired | Heart Disease

Datatype

boolean

Alias
UMLS CUI [1,1]
C0232164
UMLS CUI [1,2]
C0221099
UMLS CUI [2]
C0018799
impairment of gastrointestinal (gi) function, or gi disease that may significantly alter the absorption of lbh589
Beschrijving

Abnormal digestive tract function | Gastrointestinal Disease Changing Absorption LBH589

Datatype

boolean

Alias
UMLS CUI [1]
C0232459
UMLS CUI [2,1]
C0017178
UMLS CUI [2,2]
C0392747
UMLS CUI [2,3]
C0237442
UMLS CUI [2,4]
C1566164
ongoing diarrhea
Beschrijving

Diarrhea

Datatype

boolean

Alias
UMLS CUI [1]
C0011991
liver or renal disease with impaired hepatic or renal functions
Beschrijving

Liver disease | Kidney Disease | Liver Dysfunction | Renal Insufficiency

Datatype

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0086565
UMLS CUI [4]
C1565489
concomitant use of any anti-cancer therapy or certain drugs
Beschrijving

Cancer treatment | Antineoplastic Agents

Datatype

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C0003392
female patients who are pregnant or breast feeding
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients not willing to use an effective method of birth control
Beschrijving

Contraceptive methods Unwilling

Datatype

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0558080
other protocol-defined inclusion/exclusion criteria may apply
Beschrijving

Clinical Trial Eligibility Criteria Study Protocol

Datatype

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Terug naar het begin van de pagina

Similar models

Eligibility Breast Cancer NCT00567879

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age > 18 year old
boolean
C0001779 (UMLS CUI [1])
Secondary malignant neoplasm of female breast HER2/Neu Positive
Item
confirmed her2+ ve metastatic breast cancer
boolean
C0346993 (UMLS CUI [1,1])
C2348909 (UMLS CUI [1,2])
Trastuzumab | Disease Progression
Item
prior treatment and progression on trastuzumab
boolean
C0728747 (UMLS CUI [1])
C0242656 (UMLS CUI [2])
Normal Laboratory Test Result
Item
patients must have adequate laboratory values
boolean
C0438214 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of <2
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
CNS disorder | Metastatic malignant neoplasm to brain | Exception Prior Therapy | Exception Stable status
Item
patients with active central nervous system (cns) disease or brain metastases except those who have been previously treated and have been stable for at least 3 months.
boolean
C0007682 (UMLS CUI [1])
C0220650 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C1514463 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0205360 (UMLS CUI [4,2])
Cardiac function Impaired | Heart Disease
Item
impaired heart function or clinically significant heart disease
boolean
C0232164 (UMLS CUI [1,1])
C0221099 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2])
Abnormal digestive tract function | Gastrointestinal Disease Changing Absorption LBH589
Item
impairment of gastrointestinal (gi) function, or gi disease that may significantly alter the absorption of lbh589
boolean
C0232459 (UMLS CUI [1])
C0017178 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0237442 (UMLS CUI [2,3])
C1566164 (UMLS CUI [2,4])
Diarrhea
Item
ongoing diarrhea
boolean
C0011991 (UMLS CUI [1])
Liver disease | Kidney Disease | Liver Dysfunction | Renal Insufficiency
Item
liver or renal disease with impaired hepatic or renal functions
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0086565 (UMLS CUI [3])
C1565489 (UMLS CUI [4])
Cancer treatment | Antineoplastic Agents
Item
concomitant use of any anti-cancer therapy or certain drugs
boolean
C0920425 (UMLS CUI [1])
C0003392 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
female patients who are pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Contraceptive methods Unwilling
Item
patients not willing to use an effective method of birth control
boolean
C0700589 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial